NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
about
1α,25-Dihydroxyvitamin D3 Ameliorates Seawater Aspiration-Induced Lung Injury By Inhibiting The Translocation Of NF-κB and RhoANLR-Dependent Regulation of Inflammation in Multiple Sclerosis- Dependent Regulation of Inflammation in Multiple Sclerosis.First-episode psychosis as the initial presentation of multiple sclerosis: a case report.The Footprints of Poly-Autoimmunity: Evidence for Common Biological Factors Involved in Multiple Sclerosis and Hashimoto's Thyroiditis.Role of nuclear factor κB in multiple sclerosis and experimental autoimmune encephalomyelitis
P2860
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
@ast
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
@en
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
@nl
type
label
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
@ast
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
@en
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
@nl
prefLabel
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
@ast
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
@en
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
@nl
P2860
P921
P3181
P356
P1476
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
@en
P2093
Saskia M. Leibowitz
P2860
P3181
P356
10.3389/FNMOL.2016.00084
P407
P577
2016-09-15T00:00:00Z